Conference abstract · 2018
Conference abstractPublished 4 Aug 2015
Drug development targeting cancer stem cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Conventional anti-cancer treatment excels at tumor size reduction leading to clinically evident responses. However, these effects are frequently transient and are not associated with increased patient survival. Treatments are often too toxic to normal cells and they fail to selectively kill cancer stem cells (CSCs), which can survive treatment and, like the queen bee of a beehive, give rise to new malignant cells. Therefore CSCs are an underlying cause of tumor recurrence and metastasis. For truly effective treatments that can create a durable clinical response drugs that can target CSCs must be developed. Here we present data showing how functional assays for drug screening may be used to unravel compounds that target cancer stem cells, with a case study on drugs that inhibit activation of HIF dependent pathways.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Jun 2017
Use of 3D spheroid cultures to screen for drugs targeting cancer stem cells
Mini review · 29 Sep 2022
Methodological focuses on cancer stem cells as a therapeutic target to avoid tumour development and metastasis
Perspective · 29 May 2025
Targeting cancer stem cells: A new frontier in molecular oncology research
Commentary · 28 Jan 2023
Targeting Cancer Stem Cells: A Potential Breakthrough in Ovarian Cancer Treatment
More from this journal
The newest in Chemotherapy: Open Access.
Perspective · 3 Nov 2025
Vulvar and Vaginal Cancers Clinical Characteristics Treatment Options and Prognosis
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Angel G Martin”

